Skip to content
drillr.ai
Sign up

688068.SH

Beijing Hotgen Biotech Co., Ltd.

SSE · Healthcare · Biotechnology · CN

CNY 71.19
+2.98%
Ask drillr

  • Oct 30, 2026, 08:46 UTC

    Hotgen Biotech reported third-quarter 2026 revenue of RMB 107 million, up 3.02% year over year, and a net loss of RMB 82.7039 million; for the first nine months of 2026, revenue was RMB 375 million, up 21.93%, and the net loss was RMB 209 million.

    Source:

  • Oct 15, 2026, 12:21 UTC

    Shunjing Medicine enrolled and dosed the first participant in a Phase IIa clinical study of SGC001 injection for predicted severe acute pancreatitis.

    Source: